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Background: The optimal timing of aortic valve replacement (AVR) in patients with asymptomatic severe aortic stenosis (AS) is controversial, 
especially in patients with equivocally severe AS whose valve area (AVA) is 0.76-1.0 cm2, which is not “very severe AS”. If progression rate of AS 
could be predicted, it would be helpful to decide the timing of AVR. The purpose of this study is to examine the progression rate and its predictors in 
patients with severe AS.
Methods: We retrospectively investigated 96 consecutive patients with severe AS whose AVA is 0.76-1.0 cm2. Progression rate of AVA and aortic-
jet velocity (AV-Vel) were calculated. We examined relationship between the progression rate and clinical factors, including age, sex, coronary artery 
disease, hypertension, diabetic mellitus, dyslipidemia, hemodialysis, and echocardiographic parameters. The degree of aortic valve calcification was 
graded on a scale of mild to severe. And they were divided into two groups according to progression rate in the first year from diagnosis; 32 patients 
with progression rate>0.1cm2 in AVA (group R), and 64 with progression rate <0.1cm2(group S). Survival rate and event-free rate, with the end point 
defined as cardiac death and eventual AVR, were compared between the two groups.
Results: The follow-up period was 52±32 months. The mean progression rate was 0.07cm2/year in AVA (group R: 0.14±0.11, group S: 0.04±0.05) 
and 0.26m/s/year in AV-Vel (group R: 0.40±0.38, group S: 0.20±0.18). Moderate to severe aortic-valve calcification was a predictor of high 
progression rate (p=0.017), whereas other clinical factors did not have significant impacts on the progression rate. Cardiac death occurred in 8 
patients, and 3 of them were sudden deaths. Group R had significantly more events than group S (p<0.05), and 12.5% of group R had cardiac 
deaths during follow-up.
Conclusions: The mean progression rate in severe AS was 0.07cm2/year. Early operation may be better when progression rate in AVA is more than 
0.1cm2/year and when they have a heavily calcified aortic valve.
